image: Mouse embryonic fibroblast (MEF) cells were transfected with Caveolin1-mApple (in magenta) and treated with oleic acid for 3 hours. The intracellular lipid droplets were then stained with BODIPY (green), and caveolin-1 localization was analyzed using confocal laser-scanning microscopy.
Credit: Esther Ocket
Lipodystrophy is a rare, incurable disease in which the body's adipose tissue breaks down, causing those affected to suffer from severe metabolic disorders and a significantly reduced quality of life. The consequences of this condition include, for example, diabetes, fatty liver, and elevated blood lipid levels, chronic fatigue, hunger, pain, and fertility problems. Researchers from the University of Potsdam and the Leibniz-Forschungsinstitut für Molekulare Pharmakologie have investigated how lipodystrophy can develop and what role the gene Caveolin1 plays in this process.
Lipodystrophy is a serious metabolic disease characterized by abnormal lipid storage in the body. In people with this condition, ingested fats are not stored in adipose tissue as they are in healthy individuals, but are instead deposited in the liver, muscle tissue, or the heart muscle, among other places with far-reaching metabolic consequences such as fatty liver or type 2 diabetes. The visible redistribution of fat in the body and the other symptoms are very distressing for patients. The causes of the disease may include a congenital gene mutation, an immune disorder, or an infection.
It has previously been demonstrated that caveolae – small plasma membrane invaginations – may play a role in the development of lipodystrophy. Researchers have identified mutations in certain genes (Caveolin1 and Cavin1) in patients diagnosed with lipodystrophy. However, the exact mechanisms at work within the cells remain largely unknown.
A research team of the University of Potsdam and the Leibniz-Forschungsinstitut für Molekulare Pharmakologie has now shown that caveolin-1 plays a key role in the growth of cellular lipid droplets and, consequently, in cellular lipid storage. „We were able to identify a previously unknown transport pathway within the cells that connects caveolae on the plasma membrane to lipid droplets via an intracellular sorting station,“ says Prof. Claudia Matthäus from the Institute of Nutritional Science of the University of Potsdam, corresponding author of the study. „Our findings thus provide new insights into the molecular mechanisms of lipid storage and cellular lipid metabolism.“ These latest findings can help better understand the role of caveolin-1 in the development of lipodystrophy.
Link to Publication: E. Ocket, T. Pietrucik, L. Wong-Dilworth, D. Aik, M. Rath, D. Puchkov, M. Ruwolt, M. Lehmann, & C. Matthaeus, Lipid-induced Caveolin1 lipid droplet trafficking is associated with lipid droplet growth, Proc. Natl. Acad. Sci. U.S.A. 123 (47) e2614579123, https://doi.org/10.1073/pnas.2614579123 (2026).
Image: Mouse embryonic fibroblast (MEF) cells were transfected with Caveolin1-mApple (in magenta) and treated with oleic acid for 3 hours. The intracellular lipid droplets were then stained with BODIPY (green), and caveolin-1 localization was analyzed using confocal laser-scanning microscopy. Photo: Esther Ocket
Contact:
Prof. Dr. Claudia Matthäus, Institute of Nutritional Science
Tel.: +49 331/977-295598
E-Mail: claudia.matthaeus@uni-potsdam.de
Media Information 20-11-2026/ Nr. 094
Dr. Stefanie Mikulla
University of Potsdam
Press and Public Relations Office
Am Neuen Palais 10
14469 Potsdam
Tel.: +49 331/977-1474
Fax: +49 331/977-1130
Email: presse@uni-potsdam.de
Website: www.uni-potsdam.de/presse
Journal
Proceedings of the National Academy of Sciences
Article Title
Lipid-induced Caveolin1 lipid droplet trafficking is associated with lipid droplet growth
Article Publication Date
19-Nov-2026